Colesevelam therapy was associated with lower fasting and postprandial glucose concentrations in type 2 diabetes patients on metformin monotherapy, a study in Diabetes found. Researchers also discovered colesevelam did not affect insulin concentration, secretion or action in patients.
Colesevelam curbs glucose concentration in study
SmartBrief Job Listings for Health Care
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|
|Director Account Management||
Samaritan Health Services
|Hospital Medical Device Sales||
Linda Hertz Group